Irvin Chen

Awards as PI
Award Value
Disease Team Planning Stem Cell Therapy for AIDS- Disease Team Planning $51,490
Disease Team Research I HPSC based therapy for HIV disease using RNAi to CCR5. $9,905,604
SEED Grant Genetic modification of the human genome to resist HIV-1 infection and/or disease progression $616,800
Early Translational from Disease Team Conversion HPSC based therapy for HIV disease using RNAi to CCR5. $1,505,000
Total:
$12,078,894.00
Publications

Publications